Press Releases

Date	Title	Company
19-Sep-2023	3P Biopharmaceuticals continues its successful collaboration with Toleranzia AB to fight Myasthenia Gravis	3P Biopharmaceuticals
19-Sep-2023	Oxford BioTherapeutics to Participate in Panel Discussion at Boehringer Ingelheim’s Upcoming Transforming Science Day: Europe	Oxford BioTherapeutics
19-Sep-2023	Over 50’s back auto-enrolment in clinical trials tackling long-term health conditions	Lindus Health
19-Sep-2023	Otsuka and Astex announce that the European Commission has approved INAQOVI® (oral decitabine and cedazuridine) for the treatment of adults with newly diagnosed acute myeloid leukaemia	Otsuka Pharmaceutical Europe Ltd
19-Sep-2023	Announcing the Olink® Target 48 Mouse Cytokine Panel – the next generation in immunoassays designed to accelerate translational research	Olink Holding AB
19-Sep-2023	NecstGen and ProteoNic Report Development of Improved Viral Vectors through the Application of Premium 2G UNic™ Technology	NecstGen / ProteoNic
19-Sep-2023	European Commission authorises ViiV Healthcare’s Apretude (cabotegravir long-acting and tablets) for HIV prevention	ViiV Healthcare
19-Sep-2023	MSF urges immediate response to Nigeria’s worsening diphtheria outbreak	MSF UK
19-Sep-2023	Robots with a Laser Focus on Pharma	Stäubli Tec-Systems GmbH Robotics
19-Sep-2023	EVERSANA Unveils ACTICS® eAccess, New Technology-Enabled eBV and ePA Patient Support Platform to Improve Patient Access and Accelerate Speed to Therapy	EVERSANA
19-Sep-2023	SMC accepts AMVUTTRA®▼ (vutrisiran) as a treatment for hereditary form of amyloidosis on the NHS in Scotland	Alnylam UK Limited
19-Sep-2023	Almirall, leading manufacturer of dermatological drug products, has successfully upgraded Werum PAS-X MES for better performance and faster updatability	Körber Business Area Pharma
19-Sep-2023	Precisia Life Sciences launched to provide new intelligence for targeted medicine design	Precisia Life Sciences
19-Sep-2023	Peer-Reviewed Publication of Positive Preclinical Data of SiSaf’s SIS-ADO2 siRNA Program to Treat Rare Genetic Bone Disorder Osteopetrosis	SiSaf Ltd
19-Sep-2023	Cell and Gene Therapy Catapult launches new network for the advanced therapies industry in Scotland	Cell and Gene Therapy Catapult
19-Sep-2023	Interim Results for the Six Months ended 30 June 2023	Futura Medical plc
19-Sep-2023	Bloomsbury Genetic Therapies Announces Recent Publication of Three Articles Supporting the Preclinical Efficacy and Differentiation of BGT-OTCD as a Potential Treatment for Ornithine Transcarbamylase Deficiency (OTCD)	Bloomsbury Genetic Therapies
19-Sep-2023	CPHI Barcelona announces Pharma Award finalists	CPHI Barcelona
19-Sep-2023	BioMarin Receives Positive CHMP Opinion in Europe to Expand Use of VOXZOGO® (vosoritide) to Treat Children Aged 4 Months and Older with Achondroplasia	BioMarin
19-Sep-2023	Millions Missing Out On Essential Eye Care	Eye Health UK